Bonzai1 schreef op 10 mei 2019 08:26:
BRIEF-Acacia Pharma: Barhemsys Improves Post-Operative Nausea, Vomiting
06:14 (10/05) - Bron: Reuters
May 10 (Reuters) - ACACIA PHARMA GROUP PLC ACPH.BR :
* REG-ACACIA PHARMA’S BARHEMSYS SIGNIFICANTLY IMPROVES
POST-OPERATIVE NAUSEA & VOMITING (PONV) IN RESCUE TREATMENT OF
AMBULATORY PATIENTS
* IN NEW POST-HOC ANALYSIS, SIGNIFICANTLY MORE AMBULATORY
PATIENTS
(35 OF 68 PTS, 51%) HAD A CR IN 24 HOURS AFTER DOSING WITH 10 MG
BARHEMSYS THAN PLACEBO (21 OF 61 PTS, 34%; P=0.024)
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com;))
Bericht van Bolero. Staat uiteraard los van de goedkeuring, maar zegt wel iets over de werking van de molecule.